Journal Articles
Journal Articles
Are New Alzheimer Drugs Better than Older Drugs
JAMA Internal Medicine
Evergreened drugs or evergreened profits?
Journal of Evaluation in Clinical Practice
Journal of American Dental Association
This survey outlines dentists' beliefs regarding opioids.
Pharmaceutical marketing: the example of drug samples
Journal of Pharmaceutical Policy and Practice
This article describes how drug samples are used as a promotional tool by the pharmaceutical industry.
Challenging pharma: who cares?
Drug and Therapeutics Bulletin
Pain Physician
A study that shows the industry-funded continuing education on opioids required by the FDA under a REMS misrepresents evidence and may increase, rather than decrease, opioid prescribing.
Industry-funded medical education is always promotion
British Medical Journal
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough
Journal of General Internal Medicine
The Physician Payments Sunshine Act has not changed physician, consumer, or patient behavior and more must be done to address industry relationships in medicine
The Benefits and Risks of Adherence to Medical Therapy
Journal of Scientific Practice and Integrity
An exploration of the reasons for noncompliance to prescribed medication, its benefits and risks, and industry's stake in nonadherence
Changing Pharmaceutical Industry Interaction in US Family Medicine Residencies: A CERA Study
Journal of the American Board of Family Medicine
Interactions between pharmaceutical companies and US family residency programs decreased between 2008 and 2019. The first 2008 study was conducted by PharmedOut interns!
Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective
Journal of Bioethical Inquiry
An examination of public health activism in the Progressive Era, the postwar era and the present day.
Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED)
Journal of the American Board of Family Medicine
Marketing messages in continuing medical education promote drugs used to treat binge-eating disorder and underplay their risks.
Response: Re: Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED)
PharmedOut's response to Medscape's critique of Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED) further exposed industry marketing messages in Medscape's CME.
World Medical & Health Policy
A study on marketing messages in continuing medical education on fentanyl products.
How drug companies manipulate prescribing behavior
Colombian Journal of Anesthesiology
Discussion of common pharmaceutical industry tactics, from sales reps to CME to key opinion leaders, all to sway prescribers' opinions and therapeutic decisions.
Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia
PLOS One
How industry payments influence physicians.
Testosterone and sexual function
Current Opinion in Urology
A review on testosterone treatment for sexual function.
Treating Aging with Testosterone
American Family Physician
An editorial on on whether physicians should use testosterone to treat aging in men.
Pharmacist-industry relationships
IJPP
Documenting the diverse interactions between pharmacists and the pharmaceutical industry.
Direct-to-consumer Marketing to People with Hemophilia
PLOS Medicine
Exposing the relationships that drug manufacturers have with hemophiliac patients and their families.
Salespeople in the Surgical Suite: Relationships between Surgeons and Medical Device Representatives
PLOS One
Why is a device rep in the OR and what does it mean for patient care?
Treatment of Men for 'Low Testosterone': A Systematic Review
PLOS One
A comprehensive review that exposes Testosterone's questionable therapeutic benefits.
Taking Sides: Should Ob/Gyns Prescribe Flibanserin for their Patients?
Contemporary Ob/Gyn
Saying no to this dangerous drug.
American Journal of Nursing
An explanation of all the context nurses should need to actively recommend against Addyi.
CME Stands for Commercial Medical Education: and ACCME Still Won’t Address the Issue
Journal of Medical Ethics
Challenging the ACCME to face the relationship between industry and education.
Hypoactive Sexual Desire Disorder: Inventing a Disease to Sell Low Libido
Journal of Medical Ethics
Exploring how Big Pharma created HSDD to create a disease.
Should Family Physicians Screen for Testosterone Deficiency in Men?
American Family Physician
Dr. Fugh-Berman says No: Screening may be harmful, and benefits are unproven.
Family Medicine
A study that explores pharma influence on family medicine programs.
Physicians under the Influence: Social Psychology and Industry Marketing Strategies
The Journal of Law, Medicine & Ethics
Pharmaceutical and medical device companies apply social psychology to subconsciously influence physicians’ prescribing behavior and decision-making.
How Basic Scientists Help the Pharmaceutical Industry Market Drugs
PLOS Biology
Addresses the presence of pharma influence in biomedical research.
Promoting to Everyone, Focusing on No One: The Illogical Promotion of the Influenza Vaccine
World Medical & Health Policy
The “everyone is at risk” message associated with universal influenza vaccination could undermine effective influenza prevention efforts.
Journal of Medical Ethics
Argues that a placebo-controlled trial is unethical when a comparator that can reasonably be expected to be effective is available
PLoS Medicine
The Journal of Continuing Education in the Health Professions
Assessing physicians’ perceptions about industry relationships
Do New Drugs Increase Life Expectancy?
Journal of General Internal Medicine
A critique of a Manhattan Institute paper
The Haunting of Medical Journals
PLoS Medicine
How Ghostwriting Sold “HRT”
Ethical Considerations of Publication Planning in the Pharmaceutical Industry
Open Medicine
How industry uses medical writers to manipulate the medical literature
Off-Label Promotion, On-Target Sales
Public Library of Science
The covert promotion of drugs for unapproved uses
Thus Are Our Medical Meetings Managed (also read letter here)
British Medical Journal
Key opinion leaders may be unaware of pharma influence
Prescription Tracking and Public Health
Journal of General Internal Medicine
Why the AMA’s opt-out plan does not protect prescribing privacy
Following the Script: How Drug Reps Make Friends and Influence Doctors
Public Library of Science
Psychological techniques reps use to sell drugs
Doctors Must Not be Lapdogs to Drug Firms
British Medical Journal
Drug reps stomp out of a talk about industry influence
“This May Sting a Bit”: Cutting CME’s Ties to Pharma
Virtual Mentor
CME should go pharma-free
Advertising in Medical Journals: Should Current Practices Change?
PLoS Medicine
Taking ads for luxury goods would be less compromising to medical journals than accepting only drug ads
Gynecologists and Estrogen: An Affair of the Heart
Perspectives in Biology and Medicine
Ob-gyns believe in HT despite evidence